Prague Med. Rep. 2016, 117, 108-116

https://doi.org/10.14712/23362936.2016.11

The Effect of Infliximab on Intestinal Anastomosis Healing in Rats

Oktay Karaköse1, Hüseyin Eken1, Ali Naki Ulusoy1, Hüseyin Koray Topgül1, Mehmet Bilgin1, Saim Savaş Yürüker1, Mustafa Yavuz Gülbahar2

1Department of General Surgery, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
2Department of Pathology, Faculty of Veterinary Medicine, Ondokuz Mayis University, Samsun, Turkey

Received April 5, 2016
Accepted September 2, 2016

References

1. Bettinger, D. A., Pellicane, J. V., Tarry, W. C., Yager, D. R., Diegelmann, R. F., Lee, R., Cohen, I. K., DeMaria, E. J. (1994) The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice. J. Trauma 36, 810–813. <https://doi.org/10.1097/00005373-199406000-00010>
2. Colombel, J. F., Loftus, E. V. Jr., Tremaine, W. J., Pemberton, J. H., Wolff, B. G., Young-Fadok, T., Harmsen, W. S., Schleck, C. D., Sandborn, W. J. (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am. J. Gastroenterol. 99, 878–883. <https://doi.org/10.1111/j.1572-0241.2004.04148.x>
3. Comert, M., Taneri, F., Tekin, E., Ersoy, E., Oktemer, S., Onuk, E., Düzgün, E., Ayog˘lu, F. (2000) The effect of pentoxifylline on the healing of intestinal anastomosis in rats with experimental obstructive jaundice. Surg. Today 30, 896–902. <https://doi.org/10.1007/s005950070041>
4. Dayer, J. M., Beutler, B., Cerami, A. (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and fibroblasts. J. Exp. Med. 162, 2163–2168. <https://doi.org/10.1084/jem.162.6.2163> <PubMed>
5. Frostberg, E., Ström, P., Gerke, O., Qvist, N. (2014) Infliximab’s influence on anastomotic strength and degree of inflammation in intestinal surgery in a rabbit model. BMC Surg. 14, 23. <https://doi.org/10.1186/1471-2482-14-23> <PubMed>
6. Greenhalgh, D. G., Sprugel, K. H., Murray, M. J., Ross, R. (1990) PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 136, 1235–1242.
7. Isik, A., Eryılmaz, R., Okan, I., Dasiran, F., Firat, D., Idiz, O., Sahin, M. (2014) The use of fibrin glue without surgery in the treatment of pilonidal sinus disease. Int. J. Clin. Exp. Med. 7, 1047–1051.
8. Isik, A., Peker, K., Soyturk, M., Firat, D., Yoruker, U., Yilmaz, I. (2015a) Diagnostic evaluation and treatment of patients with rectus abdominis hematoma. Cir. Esp. 93, 580–588. <https://doi.org/10.1016/j.ciresp.2015.02.014>
9. Isik, A., Peker, K., Gursul, C., Sayar, I., Firat, D., Yilmaz, I., Demiryilmaz, I. (2015b) The effect of ozone and naringin on intestinal ischemia/reperfusion injury in an experimental model. Int. J. Surg. 21, 38–44. <https://doi.org/10.1016/j.ijsu.2015.07.012>
10. Jamall, I. S., Finelli, V. N., Que Hee, S. S. (1981) A simple method determine nanogram levels of 4-hydroxyproline in biological tissues. Anal. Biochem. 112, 70–75. <https://doi.org/10.1016/0003-2697(81)90261-X>
11. Jensen, J. S., Petersen, N. B., Biagini, M., Bollen, P., Qvist, N. (2015) Infliximab treatment reduces tensile strength in intestinal anastomosis. J. Surg. Res. 193, 145–152. <https://doi.org/10.1016/j.jss.2014.07.022>
12. Kasparek, M. S., Bruckmeier, A., Beigel, F., Muller, M. H., Brand, S., Mansmann, U., Jauch, K. W., Ochsenkuhn, T., Kreis, M. E. (2012) Infliximab does not affect postoperative complication rates in Crohn’s patients undergoing abdominal surgery. Inflamm. Bowel Dis. 18, 1207–1213. <https://doi.org/10.1002/ibd.21860>
13. Kesici, H., Ulusoy, A. N., Topgül, K., Paşaog˘lu, H., Bayraktar, N., Şenyürek, G., Karaköse, O. (2007) The effect of taurolidine on healing of colonic anastomosis in rats with obstructive jaundice. Ulus. Cerrahi Derg. 23, 1–9.
14. Marchal, L., D’Haens, G., Van Assche, G., Vermeire, S., Noman, M., Ferrante, M., Hiele, M., Bueno De Mesquita, M., D’Hoore, A., Penninckx, F., Rutgeerts, P. (2004) The risk of post-operative complications associated with infliximab therapy for Crohn’s disease: a controlled cohort study. Aliment. Pharmacol. Ther. 19, 749–754. <https://doi.org/10.1111/j.1365-2036.2004.01904.x>
15. Mathews, N. (1981) Production of an anti-tumour cytotoxin by human monocytes. Immunology 44, 135–142.
16. Mor, I. J., Vogel, J. D., da Luz, M. A., Shen, B., Hammel, J., Remzi, F. H. (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis. Colon Rectum 51, 1202–1207. <https://doi.org/10.1007/s10350-008-9364-7>
17. Nanda, K. S., Cheifetz, A. S., Moss, A. C. (2013) Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis. Am. J. Gastroenterol. 108, 40–47. <https://doi.org/10.1038/ajg.2012.363> <PubMed>
18. Oruc, N., Ozutemiz, A. O., Yukselen, V., Nart, D., Celik, H. A., Yuce, G., Batur, Y. (2004) Infliximab: A new therapeutic agent in acute pancreatitis? Pancreas 28, e1–e8. <https://doi.org/10.1097/00006676-200401000-00020>
19. Papaconstantinou, I., Zeglinas, C., Gazouli, M., Nastos, K., Yiallourou, A., Lykoudis, P., Evangelou, K., Papalois, A., Papaioannou, M., Vlachogiannakos, J., Tzathas, C. (2014) Effect of infliximab on the healing of intestinal anastomosis. An experimental study in rats. Int. J. Surg. 12, 969–975. <https://doi.org/10.1016/j.ijsu.2014.07.271>
20. Regan, M. C., Kirk, S. S., Hurson, M., Sodeyama, M., Wasserkrug, H. L., Barbul, A. (1993) Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery 113, 173–177.
21. Selvasekar, C. R., Cima, R. R., Larson, D. W., Dozois, E. J., Harrington, J. R., Harmsen, W. S., Loftus, E. V. Jr., Sandborn, W. J., Wolff, B. G., Pemberton, J. H. (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J. Am. Coll. Surg. 204, 956–962. <https://doi.org/10.1016/j.jamcollsurg.2006.12.044>
22. Siddiqui, M. A. A., Scott, L. J. (2005) Infliximab: A review of its use in Crohn’s disease and rheumatoid arthritis. Drugs 65, 2179–2208. <https://doi.org/10.2165/00003495-200565150-00014>
23. Streit, M., Beleznay, Z., Braathen, L. R. (2006) Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int. Wound J. 3, 171–179. <https://doi.org/10.1111/j.1742-481X.2006.00233.x>
24. Suzuki, S., Kurachi, K., Yokoi, Y., Tsuchiya, Y., Okamoto, K., Okumura, T., Konno, H., Baba, S., Nakamura, S. (2001) Intrahepatic cholangiojejunostomy for unresectable malignant biliary tumors with obstructive jaundice. J. Hepatobiliary Pancreat. Surg. 8, 124–129. <https://doi.org/10.1007/s005340170034>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive